Mechanistic comparison of Isoniazid Antibacterial agent used primarily as and Pinacidil based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
5
Shared Targets
45%
Jaccard Similarity
34%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Isoniazid and Pinacidil share 5 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.455 means 45% of the combined target set is bound by both compounds. The IDF-weighted score of 0.341 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Isoniazid and Pinacidil have in common?
Isoniazid and Pinacidil share 5 molecular targets with a Jaccard similarity of 45%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Isoniazid and Pinacidil be combined?
Isoniazid and Pinacidil share 5 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Isoniazid or Pinacidil?
Both Isoniazid and Pinacidil have substantial PubMed research. View their individual profiles for full evidence scores.